BELLINGER ANDREW (Chief Scientific Officer) purchased 5K shares of VERVE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $95.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/21/2021ACC: 0000899243-21-025071
Officer· Chief Scientific Officer
Since Jun 2021
+26.60K
Net shares
Net buyer
$95.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
26.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$19.00
Trade value
$95K
% of position
New position
6/21/2021
0.00→5K
Total
Net shares
+5K
Net value
$95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/21/2021 | P · Purchase | +5K | $19.00 | $95K | New position | 0.00 | 5K |
| Total | +5K | $95K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
21.60K shares
Shares
+21.60K
Strike price
19.00
Held after
21.60K
Exercisable
—
6/17/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock21.60K shares | 6/17/2021 | A · Award | +21.60K | 19.00 | — | 21.60K |